Sweet Earth Holdings Corporation

OTC: SEHCF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Vancouver, BCReports USD

#1143 of 1,394 Healthcare companies by revenuebottom-decile growth

EA Score

22D

FH 19DQ —GM 25SS 36

v0.1 · 45/100 weight · provisional

↑ growth stability, return on assets · ↓ revenue growth (YoY), 3-yr revenue growth

Methodology →

Revenue TTM

Rev growth YoY (TTM)

-100.0%

Net income (FY)

-$763.8k

Employees

—

Market cap

$6.4M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$00 CAD2025

Net income-$763.8k-1.1M CAD2025

Operating income-$751.7k-1.0M CAD2025

Total assets$1.5M2.1M CAD2025

Liabilities$2.1M2.9M CAD2025

Equity-$4.5k-6.1k CAD2025

Revenue trend

FY2019 – FY2025 · USD

FY19

FY20

$156.5k

FY21

$69.6k

FY22

$31.5k

FY23

$7.1k

FY24

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Sweet Earth Holdings Corporation booked $0 in FY2025 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

PreveCeutical Medical Inc.——Citius Pharmaceuticals, Inc.43D Glow Lifetech Corp.——AI Maverick Intel, Inc.——

Key facts

CEORobert Dubeau

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersVancouver, BC

ExchangeOTC: SEHCF

Employees—

IPO date2020-09-23

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.